Patents by Inventor Sheetal P. Dharia

Sheetal P. Dharia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Administering Elagolix
    Publication number: 20230270744
    Abstract: The present disclosure relates to the use of GnRH receptor antagonists for the treatment of endometriosis, uterine fibroids, polycystic ovary syndrome (PCOS), or adenomyosis. In particular, the present disclosure describes methods for treating such gynecological disorders, where the methods involve administration of elagolix and may further involve co-administration of a CYP2B6 substrate (e.g., bupropion) or a CYP2C19 substrate (e.g., omeprazole).
    Type: Application
    Filed: May 5, 2023
    Publication date: August 31, 2023
    Inventors: Farah N. Ali, Sheetal P. Dharia, Nael M. Mostafa, Akshanth R. Polepally, Mohamad Shebley
  • Methods of Administering Elagolix
    Publication number: 20210275527
    Abstract: The present disclosure relates to the use of GnRH receptor antagonists for the treatment of endometriosis, uterine fibroids, polycystic ovary syndrome (PCOS), or adenomyosis. In particular, the present disclosure describes methods for treating such gynecological disorders, where the methods involve administration of elagolix and may further involve co-administration of a CYP2B6 substrate (e.g., bupropion) or a CYP2C19 substrate (e.g., omeprazole).
    Type: Application
    Filed: August 27, 2020
    Publication date: September 9, 2021
    Applicant: AbbVie Inc.
    Inventors: Farah N. Ali, Sheetal P. Dharia, Nael M. Mostafa, Ahmed Nader, Akshanth R. Polepally, Mohamad Shebley